Josè Martinez

THE ABNORMAL CARBOHYDRATE COMPOSITION OF THE DYSFIBRINOGENEMIA ASSOCIATED WITH LIVER DISEASE *

J. Martinez, J. Palascak, P. Keane, 1983, Annals of the New York Academy of Sciences.

Metabolic Studies of Human Fibrinogen 'y/'y' Chain Heterogeneity

Josè Martinez, 2017 .

Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.

J. Weisel, S. Surrey, M. Keller, 2005, Blood.

Interaction of Fibrin with VE‐Cadherin

A. Ferber, Tami L. Bach, T. Bach, 2001, Annals of the New York Academy of Sciences.

HUMAN FETAL FIBRINOGEN: ITS CHARACTERISTICS OF DELAYED FIBRIN FORMATION, HIGH SIALIC ACID AND AP PEPTIDE CONTENT ARE MORE MARKED IN PRE‐TERM THAN IN TERM SAMPLES

C. McDevitt, D. Galanakis, F. Miller, 1983 .

Novel Design of Peptides to Reverse the Anticoagulant Activities of Heparin and other Glycosaminoglycans

J. D. San Antonio, B. Schick, J. Martínez, 2001, Thrombosis and Haemostasis.

The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains

J. Martínez, K. MacDonald, J. Palascak, 1983 .

Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.

J. Weisel, S. Surrey, M. Keller, 2005, Blood.